For the year ending 2025-12-31, UPB made $2,854K in revenue. -$143,443K in net income. Net profit margin of -5026.03%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration revenue | 2,854 | |||
| Research and development | 136,806 | |||
| General and administrative | 26,409 | |||
| Total operating expenses | 163,215 | |||
| Loss from operations | -160,361 | |||
| Change in fair value of preferred stock tranche right liability | 0 | |||
| Interest income | 16,933 | |||
| Other expense, net | -15 | |||
| Total other income, net | 16,918 | |||
| Net loss | -143,443 | |||
| Redeemable convertible preferred stock cumulative dividends | 0 | |||
| Net loss attributable to common stockholders | -143,443 | |||
| Basic EPS | -2.66 | |||
| Diluted EPS | -2.66 | |||
| Basic Average Shares | 53,852,752 | |||
| Diluted Average Shares | 53,852,752 | |||
Upstream Bio, Inc. (UPB)
Upstream Bio, Inc. (UPB)